Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Louis, Létinier"'
Publikováno v:
Biomedicines, Vol 10, Iss 12, p 3159 (2022)
(1) Background: Practice guidelines define drug-eluting stents (DES) as the standard of care in coronary percutaneous coronary intervention (PCI), including in acute coronary syndrome (ACS). This is based on comparisons with bare-metal stents (BMS).
Externí odkaz:
https://doaj.org/article/ccb3b72a3b144badb4fdc18ccbac5e95
Publikováno v:
Drug Safety. 46:449-456
Autor:
Louis Létinier, Amandine Ferreira, Alexandre Marceron, Marina Babin, Joëlle Micallef, Ghada Miremont-Salamé, Antoine Pariente, on behalf of the French Network of Pharmacovigilance Centres
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
Few data are available on the clinical impact of drug–drug interactions (DDIs). Most of the studies are limited to the analysis of exposure to potential DDI or the targeted impact of the combination of a few drugs or therapeutic classes. The analys
Externí odkaz:
https://doaj.org/article/34b36e956d244a82bb94786daaebd23b
Autor:
Louis Létinier, Sébastien Cossin, Yohann Mansiaux, Mickaël Arnaud, Francesco Salvo, Julien Bezin, Frantz Thiessard, Antoine Pariente
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Introduction: Drug interactions could account for 1% of hospitalizations in the general population and 2–5% of hospital admissions in the elderly. However, few data are available on the drugs concerned and the potential severity of the interactions
Externí odkaz:
https://doaj.org/article/3955bfc3580b4156a00064f6962dcd86
Autor:
Louis Létinier, Francesco Salvo, Anne Pham-Ledard, Emilie Casarotto, Mathieu Molimard, Pernelle Noize
Publikováno v:
British Journal of Clinical Pharmacology. 87:2988-2995
We described the safety profiles of all drug classes used for the treatment of advanced melanoma from the United States Food and Drug Administration Adverse Event Reporting System over the period 2008 to 2018. Adverse reactions reported in 25,900 pha
Autor:
Guillaume L, Martin, Julien, Jouganous, Romain, Savidan, Axel, Bellec, Clément, Goehrs, Mehdi, Benkebil, Ghada, Miremont, Joëlle, Micallef, Francesco, Salvo, Antoine, Pariente, Louis, Létinier
Publikováno v:
Drug Safety
Drug Safety, Springer Verlag, 2022, 45 (5), pp.535-548. ⟨10.1007/s40264-022-01153-8⟩
Drug Safety, Springer Verlag, 2022, 45 (5), pp.535-548. ⟨10.1007/s40264-022-01153-8⟩
International audience; INTRODUCTION: Adverse drug reaction reports are usually manually assessed by pharmacovigilance experts to detect safety signals associated with drugs. With the recent extension of reporting to patients and the emergence of mas
Autor:
Claire, Dumoulin, Nathalie, Ong, Hanta, Ramaroson, Louis, Létinier, Ghada, Miremont-Salamé, Véronique, Gilleron, Amélie, Daveluy, Justine, Perino
Publikováno v:
Therapie.
Autor:
Alex Hlavaty, Mathieu Molimard, Vincent Richard, Régis Bordet, Jean-Luc Cracowski, Charles Khouri, Marion Lepelley, Amelle Mouffak, Joëlle Micallef, Alexandre Bellier, Béatrice Bouhanick, Joachim Alexandre, Silvy Laporte, Pierrick Bedouch, Claire Le Jeunne, Matthieu Roustit, Laurent Bertoletti, Florian Naudet, Annie-Pierre Jonville-Béra, Louis Létinier, Manon Gabin, Louis Larrouquere, Emmanuelle Poingt
Publikováno v:
Fundamental & Clinical Pharmacology
On March 16, 2020, the French Society of Pharmacology and Therapeutics put online a national Question and Answer (Q&A) website, http://https%20%5Ch://sfpt-fr.org/covid19 on the proper use of drugs during the COVID‐19 pandemic. The working group “
Autor:
Emanuel Raschi, Louis Létinier, Jean-Luc Faillie, Francesco Salvo, Antoine Pariente, Julien Bezin, Yohann Mansiaux, Bernard Bégaud, Vanessa Labat
Publikováno v:
Drug Safety
Drug Safety, Springer Verlag, In press, 43 (8), pp.767-774. ⟨10.1007/s40264-020-00936-1⟩
Drug Safety, Springer Verlag, In press, 43 (8), pp.767-774. ⟨10.1007/s40264-020-00936-1⟩
Introduction: After a safety warning was issued for a risk of muscular injury associated with dipeptidyl peptidase-4 (DPP-4) inhibitor use, especially when co-prescribed with statins, spontaneous reporting analyses provided conflicting results. Objec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1f08d0420597992a5ad08ec50c5cdab
http://hdl.handle.net/11585/792963
http://hdl.handle.net/11585/792963
Autor:
Marie Noëlle Matta, Aurélie Lazès-Charmetant, Amélie Daveluy, Françoise Haramburu, Louis Létinier, Pascale Guéroult, Hélène Géniaux, Marie Baumevieille
Publikováno v:
Addictive Behaviors
Addictive Behaviors, Elsevier, In press, 78, pp.173-177. ⟨10.1016/j.addbeh.2017.11.021⟩
Addictive Behaviors, Elsevier, In press, 78, pp.173-177. ⟨10.1016/j.addbeh.2017.11.021⟩
Background Parachuting, also called bombing, is a way to ingest psychoactive substances wrapped into cigarette paper, toilet paper, etc. There is little data describing parachuting in terms of substances use, context of use and, most importantly, the